Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

Authors

null

Dai Manaka

Kyoto Katsura Hospital, Kyoto, Japan

Dai Manaka , Manabu Shiozawa , Masahito Kotaka , Makio Gamoh , Akio Shiomi , Akitaka Makiyama , Yoshinori Munemoto , Toshiki Rikiyama , Mutsumi Fukunaga , Takashi Ueki , Kohei Shitara , Hiroshi Shinkai , Nobuyuki Tanida , Eiji Oki , Kentaro Yamazaki , Eiji Sunami , Takeharu Yamanaka , Takayuki Yoshino , Atsushi Ohtsu , Yoshihiko Maehara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Other Colorectal and Anal Cancer

Clinical Trial Registration Number

000013036

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4011)

DOI

10.1200/JCO.2020.38.15_suppl.4011

Abstract #

4011

Poster Bd #

3

Abstract Disclosures